Research news

Caption
Drug discovery research

Test to detect early Parkinson's given FDA Breakthrough Device Designation

Date

The biotech company Amprion have developed a test to detect the early signs of Parkinson's, before the onset of symptoms, which they hope will be ready to market in the next 18 months.

Read more about <span property="schema:name" class="field field--name-title field--type-string field--label-hidden">Test to detect early Parkinson&#039;s given FDA Breakthrough Device Designation</span>
Caption
Researcher with person with Parkinson's

Phase II trial is underway investigating a gene therapy for Parkinson's

Date

Axovant Gene Therapies Ltd., a company developing innovative gene therapies, has announced they are entering the next stage of a phase II gene therapy trial for Parkinson's.

Read more about <span property="schema:name" class="field field--name-title field--type-string field--label-hidden">Phase II trial is underway investigating a gene therapy for Parkinson&#039;s</span>